Shares of Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as C$4.19 and last traded at C$4.13, with a volume of 22751 shares trading hands. The stock had previously closed at C$4.01.
Medexus Pharmaceuticals Trading Up 0.8%
The company has a 50 day moving average of C$3.96 and a 200 day moving average of C$3.28. The firm has a market cap of C$129.85 million, a price-to-earnings ratio of -201.00 and a beta of 0.53.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
